Cargando…
TET2 Overexpression in Chronic Lymphocytic Leukemia Is Unrelated to the Presence of TET2 Variations
TET2 is involved in a variety of hematopoietic malignancies, mainly in myeloid malignancies. Most mutations of TET2 have been identified in myeloid disorders, but some have also recently been described in mature lymphoid neoplasms. In contrast to the large amount of data about mutations of TET2, som...
Autores principales: | Hernández-Sánchez, María, Rodríguez, Ana Eugenia, Kohlmann, Alexander, Benito, Rocío, García, Juan Luis, Risueño, Alberto, Fermiñán, Encarna, De Las Rivas, Javier, González, Marcos, Hernández-Rivas, Jesús-María |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3947698/ https://www.ncbi.nlm.nih.gov/pubmed/24693539 http://dx.doi.org/10.1155/2014/814294 |
Ejemplares similares
-
Molecular Characterization of Chronic Lymphocytic Leukemia Patients with a High Number of Losses in 13q14
por: Rodríguez, Ana Eugenia, et al.
Publicado: (2012) -
Endogenous epitope-tagging of Tet1, Tet2 and Tet3 identifies TET2 as a naïve pluripotency marker
por: Pantier, Raphaël, et al.
Publicado: (2019) -
TET2 and TET3 loss disrupts small intestine differentiation and homeostasis
por: Ansari, Ihab, et al.
Publicado: (2023) -
Nanog-dependent function of Tet1 and Tet2 in establishment of pluripotency
por: Costa, Yael, et al.
Publicado: (2013) -
TET2, an “ambiguous” player in inflammation
por: Espinosa-Oliva, Ana María, et al.
Publicado: (2020)